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Obesity prevalence has increased worldwide over the last decades and has reached alarming rates in low middle-
income countries. Childhood has been affected by this epidemic, leading to premature dramatic health problems.
Adipose tissue is currently considered as an endocrine organ modulating an inflammatory state and important
metabolic processes (insulin resistance, hypertension, glucose intolerance) leading to consequences of the
cardiovascular system. This situation may be worst if the excess of body fat distribution such as abdominal obesity
(AO) is involved because it is associated with a more atherogenic risk profile determining the cardiometabolic risks
mainly in children and adolescents.
Hence, the knowledge regarding the association between AO and cardiometabolic factors aims to prevent and
treat the obesity in this young population, avoiding early harmful consequences of adulthood health.
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Obesity is characterized by excessive accumulation of total
body fat related to health problems and reduced quality of
life in adults and children [1]. Besides, this condition adds
greatly to the national health-care budgets [2].
The prevalence of obesity has increased in alarming
rates in developing countries. In 2013, 42 million of chil-
dren under the age of 5 were overweight or obese and
the rate of increase was 30 % higher in low middle-
income countries than that in developed countries
(where no increase was observed after around 2000). If
the trends continue by 2025, this rate may raise 70 mil-
lion of patients worldwide [1].
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compared with normal weight subjects [5]. In children
and adolescents, obesity is associated with cardiometa-
bolic risk factors such as dyslipidemia and type 2 diabetes,
which are related with atherosclerosis development [6, 7].
High cardiovascular risk (assessed by Pathobiological De-
terminants of Atherosclerosis in Youth score) was associ-
ated with carotid intima-media thickening in obese
adolescents with a fourfold higher risk of atherosclerosis
[8]. The presence of overweight in adolescence was also
associated with an increased risk of mortality from coron-
ary heart disease in adulthood (women and men) regard-
less of the individual’s weight in adulthood [9].
Otherwise, one of the most prevalent topics of discus-
sion regarding excess body fat is the question of visceral
fat depot or abdominal obesity (AO), also known as cen-
tral obesity, central fat deposition, visceral obesity, visceral
adiposity, visceral fat, truncal obesity, truncal fat, intra-
abdominal fat, and its early effects on the metabolic
changes in young populations [10]. Of note, cardiometa-
bolic risk factors are more prevalent in children and ado-
lescents with AO than those with overweight or general
obesity [11]. So, it is important to estimate the associationle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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children and adolescents [9].
Abdominal obesity contribute to an inflammatory state
and may cause abnormalities in health, triggering deleteri-
ous reactions related to insulin resistance (IR). Together
with other factors as lipid abnormalities, fibrinolysis, oxida-
tive stress, hypertension, hyperglycemia, or type 2 diabetes
are positively associated with endothelial dysfunction, lead-
ing to early atherosclerosis [12].
Knowing the disorders related to excessive AO, which
surround childhood and translate into chronic diseases
in adulthood, it is urgent to approach them and to iden-
tify vulnerable points that could be addressed in preven-
tion strategies. Therefore, the purpose of this paper is to
review the existing knowledge regarding the association
of AO with the main associated cardiometabolic risk fac-
tors such as disorders of glucose metabolism, lipid ab-
normalities, hypertension, and the metabolic syndrome
(MetS) in children and adolescents.
Obesity prevalence and risks in children and adolescents
The worldwide prevalence of overweight and obesity
among children and young adults has increased in the last
years. In children under 5 years, the prevalence of over-
weight and obesity in 1990 was 4.2 %, increasing to 6.7 %
in 2010, and in 2020, it could reach 9.1 % [13]. Among ad-
olescents, the rate of increase of obesity was about 12 %
(from 1980 to 2000) [14]. The scenario recently changed,
because in low middle-income countries, the tendency of
childhood overweight and obesity seems to rise quickly,
especially in urban areas, reaching about 30 % more when
compared with developed countries [15, 16].
Thereby, from around 2005, Latin America has shown
trends of increase in overweight/obesity similar to those
previously observed in Western Europe and North Amer-
ica, where a plateau level was reached [17]. Thus, cur-
rently the prevalence of overweight in children from Latin
America is over 25 %,whereas in adults, it is higher than
50 %.The prevalence of obesity in children also reached
more than 3 % (exception in Peru where for preschool
children it is less than 2 %), and in adults, this prevalence
is higher than 25 % [18]. In Brazilian children, overweight
prevalence ranged from 25 to 40 % and among adoles-
cents, it is 22 % in boys and 19.4 % in girls [18]. Recently,
a meta-analysis conducted in Brazil showed that the over-
all prevalence of obesity among children/adolescents was
14.1 %. Among boys, it was 16.1 % and for girls, it was
15 %, showing the highest prevalence in the southeastern
regions, mainly in the South region [19].
Concerning childhood overweight/obesity in European
countries (2009–2010), Norway showed the lowest preva-
lence (15 %), while Italy the highest prevalence (36 %) [17].
In the majority of the countries (except Italy, Czech Repub-
lic, and Slovenia), the prevalence was higher in females thanthat in males. In the USA, data from 2009–2010 showed
that 34 % of children aged 5–17 years were affected by this
epidemic [14, 17].
According to Zhang et al., the prevalence of obesity is
increasing among children and adolescents from rural
area as well, alerting for an urban-rural disparity ever
closer [20]. In children and adolescents from low middle-
income countries, obesity carries on a problem, especially
to those with fairly high socioeconomic status [21]. In
contrast, developed economies with children in lower
socio-economic status tend to show a higher prevalence
of obesity [17]. Despite efforts applied to recognize this
epidemic and to deal with, there is no decrease noted in
its occurrence, but at least a leveling off in its prevalence
[14]. Although, a stability of obesity in this young popula-
tion from developed countries is supported by Rokholm
et al. [22], it must be kept in mind that the prevalence is
higher than ever before.
Nowadays, it is known that the adipose tissue is an es-
sential endocrine organ [10]. It takes an important place
in the body related with the destination of excess dietary
lipids, which might determine body homeostasis main-
tenance or the production and regulation of certain hor-
mones, modulating an inflammatory state and important
metabolic processes (insulin resistance, atherogenesis
(endothelial dysfunction)), leading to detrimental conse-
quences of the cardiovascular system [23].
Overweight/obese children show early changes on left
cardiac structures that were not explained by blood
pressure [24] besides significant impairment of vascular
function as arterial wall stiffness [25]. That supports an
attainable cumulative cardiovascular effect of childhood
obesity on adult cardiovascular outcomes. Thus, over-
weight and obesity during childhood and adolescence
increase the risk of long-term obesity, leading to chances
of harmful consequences [23, 26].
Abdominal obesity and cardiometabolic risk factors
The pathophysiologic mechanisms linking childhood obes-
ity to cardiovascular abnormalities have not been clearly
established. Body fat distribution plays an important role
on the endothelial damage because obese subjects are more
prone to such dysfunction. Particularly, AO has been iden-
tified as a determinant of arteriosclerosis development [27].
Abdominal obesity is associated with a more atherogenic
risk profile (Fig. 1) because it increases the cardiometabolic
risk factors (lipid profile, systolic hypertension, and abnor-
mal fasting blood glucose) both in children and adolescents
[28–31]. Furthermore, approximately 16 to 18 % of children
and adolescents have AO [32]. In adolescents, the preva-
lence of AO is higher in low middle-income countries,
varying from 3.8 to 51.7 %, than in high-income countries
(8.7 to 33.2 %) [33], as it was also noticed in American chil-
dren and adolescents [34].
Fig. 1 Metabolic disorders associated with abdominal adiposity speeds up morbidity-mortality in adulthood
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with cardiometabolic risk factors is different [35]. The ex-
cessive amount of visceral adipose tissue plays a role in the
development of several metabolic disorders in pediatric
population [36]. The importance of examining AO using
low-cost anthropometric indices may contribute to identify
cardiometabolic risk factors from adolescence through
adulthood [34]. Thereby, simple anthropometric measures
of AO, such as waist circumference (considering ethnicity,
sex, and age) [37, 38], waist to hip ratio, and waist to height
ratio (independent of age, gender or race/ethnicity), could
be considered as predictors of AO [11, 39]. In this sense, a
number of studies have shown that surrogate markers of
AO are independent risk factors for type 2 diabetes
mellitus, dyslipidemia, hypertension, and coronary artery
disease [28, 40].
Disorders of glucose metabolism
Studies have shown that a high degree of obesity, especially
AO, in children and adolescents is detrimental to glucose
metabolism, regardless of the ethnic background, leading to
a high prevalence of impaired glucose tolerance [41].
Considering glucose metabolism, it is important to clarify
some definitions. Insulin resistance is a condition in which
there is a low uptake of glucose by the tissues in response
to insulin action. Glucose intolerance is a risk factor for fu-
ture diabetes and/or adverse outcomes [42] in which an in-
dividual has higher than normal levels of glucose in the
blood upon fasting or following a carbohydrate-rich meal,
being an inability to properly metabolize glucose. Type 2
diabetes is an array of dysfunctions characterized by hyper-
glycemia, resulting from the combination of varying de-
grees of resistance to insulin action, inadequate insulin
secretion, and excessive or inappropriate glucagon secretion[43]. These metabolic abnormalities result in an inflamma-
tory state, triggering cardiovascular risks to the individual.
In obese individuals, mainly with AO, hypertrophy of
adipose tissue releases high quantities of preinflamma-
tory markers (cytokines) as tumor necrosis factor alpha
(TNF-alpha) and interleukin-6 (IL-6), producing lipo-
toxicity and triggering a resistance to the action of insu-
lin by damaging the insulin receptor substrate (IRS-1).
Thus, there will be a reduced capacity to transport and
uptake glucose into the intracellular space. In case of a
high fat diet, there is a widening in adipocyte size
(hypertrophy), enhancing lipolysis, and releasing free
fatty acids (FFA) to the circulation [44]. These particles
will be deposited on the insulin-sensitive organs (lean
tissues): muscle, liver, and heart, leading to an inflamma-
tory state [45]. The described inflammatory state may
produce other undesirable effects such as endothelial-
vasomotor dysfunction [46].
Summing up, in obese people, initially, IR appears in
adipose tissue and then in other tissues, leading to glucose
intolerance. As a consequence, pancreatic β cells try to
produce more and more insulin to reverse this situation,
which does not occur, following up the resistance to them.
The persistence of long-term hyperglycemia leads to the
onset of type 2 diabetes [47].
In children and adolescents, epidemiological studies
show an association between AO with such disorders,
driving important and premature cardiometabolic risk in
adulthood. The homeostatic model assessment (HOMA)
index is a method to quantify IR, calculated as the prod-
uct of fasting plasma insulin level (microU/ml) and fast-
ing plasma glucose level (mmol/L), divided by 22.5 [48].
There is no widely agreed cutoff to define IR in children
and adolescents; however, some values have been
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pubertal development [50].
Once IR appears the foremost to development of MetS
[51] in the pediatric population, associated with the
other manifestations of the MetS. Although, the impact
by which AO affects MetS risk in children and adoles-
cents is unclear, studies have shown that the strongest
metabolic impact of AO is IR [52].Moreover, the preva-
lence of glucose intolerance among children and adoles-
cents was higher among girls (4.2 %) as compared with
boys (3.2 %) and was even higher when AO was present
in girls (12.7 %) [53].
Lipid abnormalities
Several chronic conditions such as obesity and dia-
betes may exacerbate the development of atheroscler-
osis [54], a process that begins as early as the first
years of life [6, 55–57]. Atherogenesis has been asso-
ciated with dyslipidemia, being an important risk fac-
tor for atherosclerosis and cardiovascular diseases,
also in the pediatric population [58].
Atherogenic dyslipidemia is one of the metabolic abnor-
malities that define the MetS and is characterized by
hypertriglyceridemia, increased levels of very-low-density
lipoprotein (VLDL) and small dense low-density lipoprotein
(LDL) particles, and reduced levels of high-density lipopro-
tein (HDL) [59]. General obesity is strongly associated with
atherogenic dyslipidemia in youth [60]. Several studies
show an association between AO and abnormal lipid profile
in children and adolescents [11, 35, 58, 61–66], especially
associated with high low-density lipoprotein cholesterol
(LDL-C), low high-density lipoprotein cholesterol (HDL-C),
and hypertriglyceridemia at all ages [67–70].
Moreover, AO promote a cluster of atherogenic risk
factors [71, 72].
During the last decade, the atherogenic dyslipidemia
prevalence is increasing in children and adolescents with
obesity [73, 74]. Data from the Third National Health and
Nutrition Examination Survey (NHANES III) indicate that
25 % of adolescents are characterized by high triglyceride
(TG) concentrations and 40 % by low HDL cholesterol
concentrations [60, 75]. The AVENA (Alimentación y
Valoración del Estado Nutricional en Adolescentes) study,
in Spanish adolescents, found a deleterious effect of both
abdominal and truncal obesity on the lipid profile [76]. In
the Bogalusa Heart Study, overweight schoolchildren were
2.4 to 7.1 times more likely to have elevated total choles-
terol (TC), LDL cholesterol, and TG than their lean coun-
terparts [60, 77].
The “portal free fatty acid” theory [78] was the first hy-
pothesis explaining the close relationship between AO
and metabolic complications. Due to its close proximity to
the liver and drained by the portal circulation, excess
visceral adipose tissue could alter lipoprotein metabolismmainly by inducing an overproduction of large
triglyceride-rich lipoproteins, VLDLs [23]. Non-esterified
FFAs released from the visceral adipose tissue are trans-
formed into VLDLs enriched with TGs which leads to the
formation of TG-rich LDL particles, which become re-
modeled into small and dense LDL particles, the most
atherogenic form of dyslipidemia [79]. Thus, a high pro-
portion of small and dense LDL has been associated with
an increased risk of coronary heart disease.
Atherogenic dyslipidemia is associated with other compo-
nents of the MetS and is an important risk factor for car-
diovascular diseases [59, 73, 80]. Accordingly, AO represent
one of the most important factors of its progression in chil-
dren with obesity [81]. Currently, the literature shows novel
merged dyslipidemic patterns in children and adolescents
associated with obesity that consist in a moderate-to-severe
elevation in TGs and non-HDL-C, mild elevation in LDL-
C, and reduced HDL-C, showing a high atherogenic pattern
[74]. This pattern of combined dyslipidemia is represented
as both an increase in small, dense LDL and in overall LDL
particle number and a reduction in total HDL-C and in
large HDL particles [82–84].
In adults, children, and also in adolescents, AO may
be associated with compositional changes in HDL parti-
cles, making them less efficient regarding their protect-
ive action on cholesterol efflux [85]. It is well known
that low levels of HDL are associated with an increased
risk of developing cardiovascular diseases [86]; however,
high levels of HDL may not always be protective, since
in a context of chronic inflammation, HDL particles may
be less functional [87].
The association between AO and dyslipidemia is a
complex trait that is associated with several metabolic
diseases (e.g., insulin resistance, non-alcoholic fatty liver
disease, chronic inflammation) during life [74], suggest-
ing an integrated pathophysiological response to exces-
sive weight gain.
Hypertension
Blood pressure (BP) is an easy and common measure-
ment in health surveys, and it is well established that
high BP can be identified in children and adolescents
[88, 89]. In several epidemiological studies, hypertension
prevalence has significantly increased among this young
population over the recent years [90–96]. Numerous
studies show that both overweight and obesity were as-
sociated with elevated BP in children and adolescents
[91, 94, 97]. Moreover, data from clinical studies on high
BP in childhood show that primary hypertension is com-
monly associated with other cardiovascular risk factors
as well as obesity [98].
Regarding AO, a previous study assessing the associ-
ation between fat distribution and cardiovascular risk in
children showed that visceral fat (as well as total fat) is
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association has also been established by several re-
searchers [28, 61, 94, 100–106]. Some of these studies
showed that this association was stronger in boys than
in girls [104–106], and the association of AO with sys-
tolic hypertension have been seen more frequently than
with diastolic hypertension [107, 108]. In a recent
systematic review by Kelishadi et al., they found only
one study showing that total body fat is a stronger
predictor of elevated BP than AO in children and
adolescents [28, 109].
Abdominal obesity plays a more important role in the oc-
currence of hypertension than subcutaneous adiposity
[110]. The anatomical location may be the answer about
functional differences between visceral and subcutaneous
adipocytes. The accumulation of visceral fat promotes a
greater activation of sympathetic nervous system (SNS)
than subcutaneous fat [111], producing more proinflamma-
tory cytokines (TNF-alpha and IL-6) and less adiponectin,
resulting in insulin resistance. Further, hyperinsulinemia
may result in the raise of sodium reabsorption (hypervole-
mia) and an increase of SNS (vasoconstriction) activity,
contributing to hypertension [110, 112].
Metabolic syndrome
In 2005, the International Diabetes Federation (IDF) de-
fined MetS in adults “as a cluster of risk factors for car-
diovascular diseases and type 2 diabetes mellitus,
including AO, atherogenic dyslipidemia (high TGs and
low HDL-cholesterol, elevated apolipoproteina B (Apo
B), small-dense LDL particles, and small HDL particles;
all of these abnormalities are individually atherogenic)
[113], impaired glucose tolerance and hypertension”
[114]. MetS could be also defined as a grouping of ab-
normalities resulting from IR and the excess of AO
[113]. Thus, two potential causative factors in the
pathogenesis of MetS stand out: IR and AO.
In the South region of Brazil, a high prevalence of
MetS among adolescents with AO and IR was observed
[115]. Weiss et al. stated that, in children and adoles-
cents, MetS is far more common than formerly reported
and its prevalence increases directly with the degree of
obesity [116]. In a systematic review, Friend et al. [117]
found that the prevalence of MetS in the general popula-
tion of children and adolescents worldwide was 3.3 %
(range 0–19.2 %); in overweight, 11.9 % (2.8–29.3 %) and
it was 29.2 % (10.0–66.0 %) in the obese population. For
non-obese, non-overweight children and adolescents was
lower than 1 %.
Waist circumference is an independent predictor of
cardiovascular risk in adults and children and an indica-
tor of IR, dyslipidemia, and hypertension. Waist circum-
ference measurement is easy and cheap, and it is
considered a clinical parameter to infer the degree ofabdominal adiposity [118] but it may vary depending on
the ethnic group. In addition, there is no consensus in
the literature on the standard cutoff points, for classifi-
cation of AO in children and adolescents [119].
Subjects with MetS usually manifest a proinflammatory
state (elevated high sensitive C-reactive protein (CRP), ele-
vated unhealthy cytokines (TNF-alpha, IL-6), decrease adi-
ponectin plasma concentrations) and a prothrombotic state
(fibrinolytic factors—plasminogen activator inhibitor-1
(PAI-1)) [114]. Individuals with MetS in which diabetes is
not already present have five times more risk of developing
type 2 diabetes [120]. Nevertheless, the identification of
MetS in children and adolescents through clinical and
metabolic factors should be done earlier to allow risk strati-
fication on the onset of type 2 diabetes and cardiovascular
diseases in this population [118].
Concerning the pediatric population, based on previous
studies [75, 116, 121–123], the IDF suggested modified
adult criteria to be applied in children and adolescents.
In addition, MetS should not be diagnosed in children
younger than 10 years, but in those with AO (90th per-
centile as a cutoff for waist circumference), they should
“work on weight reduction,” with healthy changes on
lifestyle. For children aged 10 years till 16 years old,
MetS can be determined by the presence of AO and two
or more clinical risk factors such as high triglycerides
(≥150 mg/dl), low HDL-cholesterol(<40 mg/dl), high
blood pressure(95th percentile), or high fasting plasma
glucose(>100 mg/dl). For adolescents aged 16 years or
more, the IDF adult criteria can be used [124]. However,
considering children and adolescents, some studies have
proposed scientific evidence’s items to evaluate and
characterize this population with metabolic risk factors,
since there is not an updated and precise definition.
These items include personal and family history,
pubertal status, metabolic abnormalities, and clinical
feature [125, 126].
Defining body composition or metabolic abnormalities
in children through single cutoff points is difficult be-
cause they change with age, sex, and pubertal develop-
ment, but this is not been taken into account duly, once
current definitions have considered the age rather than
the pubertal status. In accordance, studies have shown a
high prevalence of MetS, not only in pubertal but also in
prepubertal obese children [127, 128].
Prepubertal obese children [129] showed an elevation
of proinflammatory factors (TNF-alpha, IL-6, CPR, PAI-
1), and markers of endothelial dysfunction which con-
tribute to early increase of cardiovascular diseases later
in life. Likewise, serum myeloperoxidase (MPO) level
was elevated in prepubertal obese children [129]. MPO
is an enzyme which has bactericidal action and plays an
important role in the onset and progression of acute and
chronic inflammatory diseases.
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According to the literature, children and adolescents
with obesity are more likely to develop cardiovascular
risk factor and MetS. Abdominal obesity plays an im-
portant role on the pathophysiological process, linking
obesity to atherosclerosis and cardiovascular diseases,
clearly involving a chronic inflammatory state. Abdom-
inal obesity leads to insulin resistance and the develop-
ment of type 2 diabetes.
The goal should be to focus on the prevention and treat-
ment of obesity in childhood and young adulthood, since
its complications are harmful to health, leading to serious
outcomes in later life. Hence, it becomes of great import-
ance the awareness on individuals at high risk of overweight
and obesity, mainly children and adolescents. The attention
on their lifestyle is urgent, considering the quality of dietary
habits and avoiding “obesogenic” environments, encour-
aging and increasing physical activity in groups, and ad-
equate sedentary behavior to reduce it mostly during
leisure time. Understand and build up an early behavior of
healthy habits would be the basis for a future life with more
health and wellness.
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